Last reviewed · How we verify

NCT03533647

Development and Pathological Changes of High Myopia Among Children and Adolescents in China

Status unknown Last updated 20 June 2018
What this trial tests

trial testing Observational in High Myopia in 1,400 participants. Status unknown.

Timeline
14 May 2018
Primary endpoint
13 May 2021
31 May 2021

Quick facts

Lead sponsorZhongshan Ophthalmic Center, Sun Yat-sen University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,400
Start date14 May 2018
Primary completion13 May 2021
Estimated completion31 May 2021
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University

Who can join

Adults 6 to 18, any sex, with High Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to observe the relationship between the changes of ocular structure parameters and pathological changes among children and adolescents with high myopia. Environmental factors and family history will also be collected to explore their impacts on high myopia progression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Observational

Trials testing the same drug.

Other recruiting trials for High Myopia

Currently open trials in the same condition.

Other Zhongshan Ophthalmic Center, Sun Yat-sen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing